Literature DB >> 849100

[Utilization of trimethylammonium-compounds by Acinetobacter calcoaceticus (author's transl)].

H Seim, H Aurich, E Strack.   

Abstract

The utilization of carnitine and carnitine derivatives (O-acylcarnitines, carnitine carboxylderivatives) and structure-related trimethylammonium-compounds (betaines and nitrogen-bases) by Acinetobacter calcoaceticus was studied by means of the control of growth and the quantitative detection of metabolites. The strain grew only on L-carnitine, L-O-acylcarnitines, and gamma-butyrobetaine as the sole carbon sources. The utilization of these compounds and the growth correlated with the cleavage of the C-N bond and thereby with the formation of trimethylamin. D-Carnitine was metabolized, if an additional carbon source, like L-carnitine, was present in the incubation mixture, or if the bacteria were preincubated with L- or DL-carnitine, but no growth was observed on D-carnitine as the sole carbon source. The bacteria oxidized choline to glycinebetaine in the presence of additional carbon sources, glycinebetaine itself was not assimilated. With regard to the catabolism of quaternary nitrogen compounds Acinetobacter calcoaceticus shows a different pathway in comparison with other bacterial species metabolizing carnitine.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 849100     DOI: 10.1007/BF00429336

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  17 in total

1.  Anaerobic degradation of choline. I. Fermentation of choline by an anaerobic, cytochrome-producing bacterium, Vibrio cholinicus n. sp.

Authors:  H R HAYWARD; T C STADTMAN
Journal:  J Bacteriol       Date:  1959-10       Impact factor: 3.490

2.  Carnitine.

Authors:  G FRAENKEL; S FRIEDMAN
Journal:  Vitam Horm       Date:  1957       Impact factor: 3.421

3.  An adaptive bacterial cholinesterase from a Pseudomonas species.

Authors:  D B GOLDSTEIN; A GOLDSTEIN
Journal:  J Gen Microbiol       Date:  1953-02

4.  Role of lysine and -N-trimethyllysine in carnitine biosynthesis. I. Studies in Neurospora crassa.

Authors:  D W Horne; H P Broquist
Journal:  J Biol Chem       Date:  1973-03-25       Impact factor: 5.157

5.  Microbiological assay of carnitine.

Authors:  L R Travassos; C O Sales
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

6.  [Use of n-alkanes by an Acinetobacter calco-aceticus strain].

Authors:  H P Kleber; W Schöpp; H Aurich
Journal:  Z Allg Mikrobiol       Date:  1973

7.  [Preparation of O-acylcarnitines].

Authors:  E Strack; D M Müller
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1970-01

8.  Formation of trimethylamine from DL-carnitine by Serratia marcescens.

Authors:  T Unemoto; M Hayashi; K Miyaki; M Hayashi
Journal:  Biochim Biophys Acta       Date:  1966-05-26

9.  Inducible gamma-butyrobetaine-degrading enzymes in Pseudomonas species AK 1.

Authors:  G Lindstedt; S Lindstedt; T Midtvedt; M Tofft
Journal:  J Bacteriol       Date:  1970-03       Impact factor: 3.490

10.  Role of carnitine in hepatic ketogenesis.

Authors:  J D McGarry; C Robles-Valdes; D W Foster
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

View more
  12 in total

1.  l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans.

Authors:  Robert A Koeth; Betzabe Rachel Lam-Galvez; Jennifer Kirsop; Zeneng Wang; Bruce S Levison; Xiaodong Gu; Matthew F Copeland; David Bartlett; David B Cody; Hong J Dai; Miranda K Culley; Xinmin S Li; Xiaoming Fu; Yuping Wu; Lin Li; Joseph A DiDonato; W H Wilson Tang; Jose Carlos Garcia-Garcia; Stanley L Hazen
Journal:  J Clin Invest       Date:  2018-12-10       Impact factor: 14.808

2.  Metabolism of D: (+)-carnitine by Escherichia coli.

Authors:  H Jung; H-P Kleber
Journal:  Appl Microbiol Biotechnol       Date:  1991-06       Impact factor: 4.813

Review 3.  Carnitine in bacterial physiology and metabolism.

Authors:  Jamie A Meadows; Matthew J Wargo
Journal:  Microbiology       Date:  2015-03-18       Impact factor: 2.777

4.  γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO.

Authors:  Robert A Koeth; Bruce S Levison; Miranda K Culley; Jennifer A Buffa; Zeneng Wang; Jill C Gregory; Elin Org; Yuping Wu; Lin Li; Jonathan D Smith; W H Wilson Tang; Joseph A DiDonato; Aldons J Lusis; Stanley L Hazen
Journal:  Cell Metab       Date:  2014-11-04       Impact factor: 27.287

5.  Transport of gamma-butyrobetaine in an Agrobacterium species isolated from soil.

Authors:  S Nobile; J Deshusses
Journal:  J Bacteriol       Date:  1986-11       Impact factor: 3.490

6.  Carnitine metabolism in the human gut: characterization of the two-component carnitine monooxygenase CntAB from Acinetobacter baumannii.

Authors:  Marco Massmig; Edward Reijerse; Joern Krausze; Christoph Laurich; Wolfgang Lubitz; Dieter Jahn; Jürgen Moser
Journal:  J Biol Chem       Date:  2020-07-21       Impact factor: 5.157

7.  [Interrelationships between carnitine metabolism and fatty acid assimilation in Pseudomonas putida (author's transl)].

Authors:  H P Kleber; H Seim; H Aurich; E Strack
Journal:  Arch Microbiol       Date:  1978-02       Impact factor: 2.552

8.  Crotonobetaine reductase from Escherichia coli--a new inducible enzyme of anaerobic metabolization of L(-)-carnitine.

Authors:  S Roth; K Jung; H Jung; R K Hommel; H P Kleber
Journal:  Antonie Van Leeuwenhoek       Date:  1994       Impact factor: 2.271

9.  Stimulation of the anaerobic growth of Salmonella typhimurium by reduction of L-carnitine, carnitine derivatives and structure-related trimethylammonium compounds.

Authors:  H Seim; H Löster; R Claus; H P Kleber; E Strack
Journal:  Arch Microbiol       Date:  1982-07       Impact factor: 2.552

Review 10.  Trimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease.

Authors:  Diede Fennema; Ian R Phillips; Elizabeth A Shephard
Journal:  Drug Metab Dispos       Date:  2016-05-17       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.